Latest news, Events and Press Releases

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.

News Press releases Events Publications

Curium Expands PYLCLARI® Rights to 56 Additional Countries, Bringing Precision Prostate Cancer Imaging Closer to Patients Worldwide

30th September 2026

Sunrise Walk & Run

28th September 2026

39th Annual Congress of the European Association of Nuclear Medicine

28th September 2026

Curium expands long-standing collaboration with the University of Missouri Research Reactor to strengthen the U.S. supply chain for a critical cancer isotope

28th September 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

16th September 2026

Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology

10th August 2026

Curium Announces Definitive Agreement to Merge with Lantheus

3rd August 2026

Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine

30th July 2026

Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs

27th July 2026

Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs

18th June 2026

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

11th June 2026

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

1st June 2026

1 2 … 10